Home › Blood Cancers › Ohio › Akron
Blood Cancers clinical trials in Akron, OH
4 studies for Blood Cancers are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Summa Health System - Barberton Campus, Barberton · 7 mi away
- and 1 more
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
RecruitingPhase 1
- Gabrail Cancer Center, Canton · 21 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Childrens Hospital Medical Center of Akron, Akron
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
RecruitingPhase 1
- Gabrail Cancer Center, Canton · 21 mi away
Blood Cancers trials in other cities
- Houston, TX46 studies
- Boston, MA28 studies
- New York City, NY26 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Baltimore, MD18 studies
- Los Angeles, CA18 studies
- Durham, NC16 studies
- Chicago, IL16 studies
- Edison, NJ14 studies
- Columbus, OH14 studies
- Philadelphia, PA14 studies
Other studies in Akron
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Breast Cancer14 studies
- Cancer (all types)13 studies
- Prostate Cancer10 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Small Cell Lung Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Melanoma8 studies
- Steatotic Liver Disease7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.